Carter Worth of Cornerstone Macro spoke on CNBC's "Fast Money," about stocks that could outperform in the second half of the year.
iShares NASDAQ Biotechnology Index /zigman2/quotes/206189322/composite IBB +1.46% has been trading sideways for the last three years and it is finally breaking out on the upside. He expects it to continue to move higher.
iShares Silver Trust /zigman2/quotes/205744453/composite SLV +0.39% could trade much higher, said Worth. He noticed a rounding bottom technical pattern on its charts and he wants to buy it.
Thermo Fisher Scientific Inc. /zigman2/quotes/201150432/composite TMO +2.19% and Danaher Corporation /zigman2/quotes/210555154/composite DHR +2.95% have outperformed both SPDR S&P 500 ETF Trust /zigman2/quotes/209901640/composite SPY +1.39% and PowerShares QQQ Trust /zigman2/quotes/208575548/composite QQQ +2.52% over a five-year period. They are not overdone because they have a lower beta than the market, explained Worth.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.